Jeong Won Kim Selected Research

Jeong Won Kim Research Topics

Disease

11	Neoplasms (Cancer) 11/2020 - 09/2003
3	Hypoxia (Hypoxemia) 01/2012 - 05/2010
2	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2020
2	Heart Arrest (Cardiac Arrest) 11/2017 - 03/2017
2	Colorectal Neoplasms (Colorectal Cancer) 10/2017 - 01/2017
2	Rupture 03/2017 - 11/2010
2	Papillary Thyroid Cancer 09/2015 - 01/2014
2	Carcinogenesis 12/2014 - 10/2011
2	Carcinoma (Carcinomatosis) 01/2014 - 10/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2012 - 04/2008
1	Ischemia 01/2021
1	Necrosis 01/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021
1	Chronic Limb-Threatening Ischemia 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 03/2019
1	Inflammation (Inflammations) 01/2019
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019
1	Adenocarcinoma 10/2017
1	Wounds and Injuries (Trauma) 03/2017
1	Pigmented Nevus (Melanocytic Nevus) 09/2016
1	Vascular System Injuries 10/2015
1	Emergence Delirium 10/2015
1	Foreign Bodies (Foreign Body) 10/2015
1	Metaplasia 12/2014
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2014
1	Lymphatic Metastasis 01/2014
1	Hyperplasia 01/2014
1	Adenoma (Adenomas) 01/2014
1	Thyroiditis 01/2014
1	Pancreatitis 10/2012
1	Plasma Cell Granuloma 10/2012
1	Immunoglobulin G4-Related Disease 10/2012
1	Pleomorphic Adenoma 10/2011
1	Hepatocellular Carcinoma (Hepatoma) 08/2011
1	Gallbladder Neoplasms (Gallbladder Cancer) 08/2011
1	Urinary Bladder Calculi (Bladder Calculi) 08/2011
1	Acute Cholecystitis 08/2011
1	Appendicitis 11/2010
1	Multiple Sclerosis 11/2010
1	Hematoma 06/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2017 - 10/2011
3	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 09/2003
2	ParaffinIBA 01/2020 - 04/2017
2	Biological ProductsIBA 03/2019 - 10/2017
2	Indicators and Reagents (Reagents)IBA 10/2017 - 01/2017
2	Anesthetics (Anesthetic Agents)IBA 10/2015 - 11/2010
2	Gemcitabine FDA Link 06/2012 - 04/2008
2	MetalsIBA 01/2012 - 11/2010
1	Formaldehyde (Formol)FDA Link 01/2020
1	Growth Factor ReceptorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	LigandsIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	atezolizumabIBA 01/2020
1	MucinsIBA 03/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 10/2017
1	Cadherins (E-Cadherin)IBA 10/2017
1	CateninsIBA 10/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 10/2017
1	mangion-purified polysaccharide (Candida albicans)IBA 10/2017
1	SilverIBA 04/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2017
1	Ketamine FDA LinkGeneric 10/2015
1	Pepsinogen A (Pepsinogen)IBA 12/2014
1	GastrinsIBA 12/2014
1	Immunoglobulins (Immunoglobulin)IBA 10/2012
1	Immunoglobulin G (IgG)IBA 10/2012
1	Clioquinol (Vioform)FDA Link 01/2012
1	IonsIBA 01/2012
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2011
1	Phenobarbital (Luminal)FDA Link 10/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011
1	potassium titanylphosphateIBA 08/2011
1	yttrium-aluminum-garnetIBA 08/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 07/2011
1	Oxygen (Dioxygen)IBA 07/2011
1	graphene oxideIBA 11/2010
1	Mixed Function Oxygenases (Monooxygenases)IBA 05/2010
1	beta-thujaplicinIBA 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 04/2008

Therapy/Procedure

5	Therapeutics 01/2021 - 04/2008
2	Induced Hypothermia 11/2017 - 03/2017
2	Laparotomy 08/2011 - 11/2010
1	Limb Salvage 01/2021
1	Transplantation 01/2021
1	Surgical Amputation (Amputations) 01/2021
1	Cardiopulmonary Resuscitation (CPR) 11/2017
1	Gas Lasers 09/2016
1	Minimally Invasive Surgical Procedures 10/2015
1	Stents 10/2015
1	Thyroidectomy 01/2014
1	Lymph Node Excision (Lymph Node Dissection) 01/2014
1	Cholecystectomy 08/2011
1	Solid-State Lasers 08/2011
1	Electrodes (Electrode) 11/2010
1	Conservative Treatment 06/2010
1	Drug Therapy (Chemotherapy) 04/2008